Income Statement (TTM)
U.S. Stem Cell, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
|
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change (%) | -41.13 | 9.70 | -1.39 | -2.44 | -31.36 | -30.42 | -7.82 | -33.46 | -4.22 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change (%) | -71.29 | -4.02 | -5.20 | -7.50 | -3.59 | -15.73 | -16.95 | -24.54 | -13.51 | |
% of Revenue | 47.45 | 23.14 | 20.25 | 19.46 | 18.45 | 25.92 | 31.39 | 28.28 | 32.07 | 28.97 |
Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change (%) | -13.91 | 13.83 | -0.42 | -1.22 | -37.64 | -35.56 | -3.65 | -36.98 | 0.16 | |
% of Revenue | 52.55 | 76.86 | 79.75 | 80.54 | 81.55 | 74.08 | 68.61 | 71.72 | 67.93 | 71.03 |
SG&A | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Change (%) | -9.71 | 0.71 | 11.84 | -16.69 | -6.83 | -1.11 | -15.48 | -7.46 | 0.66 | |
% of Revenue | 614.89 | 943.10 | 865.76 | 981.88 | 838.41 | 1,138.03 | 1,617.41 | 1,483.06 | 2,062.74 | 2,167.93 |
R&D | 0 | |||||||||
Change (%) | ||||||||||
% of Revenue | 0.00 | |||||||||
OpEx | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Change (%) | -14.12 | 0.59 | 11.45 | -16.52 | -6.76 | -1.44 | -15.51 | -7.78 | 0.44 | |
% of Revenue | 662.34 | 966.24 | 886.00 | 1,001.34 | 856.86 | 1,163.94 | 1,648.79 | 1,511.34 | 2,094.81 | 2,196.90 |
Operating Income | -3 | -2 | -2 | -3 | -2 | -2 | -2 | -2 | -2 | -2 |
Change (%) | -9.32 | -0.46 | 13.08 | -18.08 | -3.51 | 1.29 | -16.00 | -5.96 | 0.68 | |
% of Revenue | -562.34 | -866.24 | -786.00 | -901.34 | -756.86 | -1,063.94 | -1,548.79 | -1,411.34 | -1,994.81 | -2,096.90 |
Interest Expense | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
Change (%) | 4.05 | 15.00 | 11.04 | 1.59 | 57.86 | -0.08 | 0.85 | 0.63 | -31.97 | |
% of Revenue | -99.71 | -176.25 | -184.77 | -208.04 | -216.64 | -498.21 | -715.49 | -782.82 | -1,183.90 | -840.93 |
Net Income | -3 | -3 | -3 | -4 | -3 | -3 | -3 | -3 | -3 | -3 |
Change (%) | -2.93 | 13.98 | 12.90 | -12.99 | 1.59 | 5.36 | -12.24 | -3.52 | -2.54 | |
% of Revenue | -632.64 | -1,043.17 | -1,083.79 | -1,240.78 | -1,106.54 | -1,637.58 | -2,479.60 | -2,360.60 | -3,422.93 | -3,483.21 |
Source: Capital IQ